انگلیسی مرکز تحقیقات پزشکی مبتنی بر شواهد | NICTH with secondary acromegaloid changes and severe hypoglycemi

انگلیسی مرکز تحقیقات پزشکی مبتنی بر شواهد | NICTH with secondary acromegaloid changes and severe hypoglycemi
| May 20 2026
logo

Evidence Based Medicine Research Center

  • Release Date : Feb 18 2026 - 12:06
  • : 1
  • Study time : Less than one minute

NICTH with secondary acromegaloid changes and severe hypoglycemia due to potentially insulin-like growth factor-2 mediated effects

Non-islet cell tumor hypoglycemia (NICTH) is a rare paraneoplastic syndrome resulting from excessive secretion of pro-insulin-like growth factor 2 (proIGF-2).

 {faces}

This leads to hypoinsulinemic hypoglycemia and, in some cases, acromegaly. We report the case of a 52-year-old woman with NICTH syndrome who had decreased levels of insulin-like growth factor 1 (IGF1), insulin, C-peptide, and growth hormone (GH). The patient experienced severe hypoglycemia, with blood glucose levels dropping to 42 mg/dL (normal reference range; 70–100 mg/dL and SI unit; 2.33 mmol/L), resulting in tachycardia, palpitations, and confusion.

 

Additionally, the patient exhibited acromegaloid features, such as a coarse facial appearance and hyperpigmentation. The patient presented with shortness of breath and chest pain. A mass was found in her left lung, which was successfully removed through thoracotomy surgery, resolving her hypoglycemic symptoms. 

  • Article_DOI :
  • Author(s) :
  • News Group : article,karshenas article
  • News Code : 321283
مدیر سایت
Author:

مدیر سایت

0 Comments for this article

comment

Post your comment:

متن درون تصویر را در جعبه متن زیر وارد نمائید *
Enter your desired term to search
Theme settings